FRM
NUVB icon

Fox Run Management’s Nuvation Bio NUVB Stock Holding History

Fox Run Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,586
Closed -$185K – 1191
2026
Q1 		$185K Buy
+45,586
New +$254K 0.03% 777

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fox Run Management's NUVB Position: Q2 2026 in Review

Fox Run Management sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 45,586 shares — an estimated $185K sold.

Fox Run Management first reported a position in NUVB in Q1 2026 and held it in 1 quarter. The position peaked at $185K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Fox Run Management reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 45,586 Nuvation Bio shares in Q2 2026, an estimated $185K.
  • Fox Run Management first reported a position in Nuvation Bio in Q1 2026 and held it in 1 quarter.
  • Fox Run Management's Nuvation Bio position peaked at $185K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.